CJC-1295 With DAC vs CJC-1295 Without DAC: Research Comparison
A Side-By-Side Research Comparison Of CJC-1295 With DAC And CJC-1295 Without DAC - the DAC versus non-DAC forms of the CJC-1295 GHRH analog. This Reference Compares Mechanism, Evidence Tier, Molecular Identity, And Pharmacokinetics For Qualified Researchers. For In Vitro Laboratory Research Use Only. Not Medical Advice Or Dosing Guidance.
Side-By-Side Comparison
| CJC-1295 With DAC | CJC-1295 Without DAC | |
|---|---|---|
| Category | Muscle Growth & Performance | Muscle Growth & Performance |
| Compound Class | Long-acting synthetic GHRH analog with Drug Affinity Complex (DAC) albumin-binding moiety | Short-acting synthetic GHRH analog (Mod GRF 1-29); no albumin-binding DAC moiety |
| Evidence Tier | Research Compound | Research Compound |
| Molecular Target | GHRH receptor (GHRHR) on pituitary somatotrophs; sustained GH and IGF-1 elevation | GHRH receptor (GHRHR) on anterior pituitary somatotrophs; augments natural pulsatile GH release |
| Molecular Weight | 3647.1 Da | 3357.9 Da |
| Amino Acid Sequence | tetrasubstituted GRF(1-29) + DAC | tetrasubstituted GRF(1-29) amide |
| CAS Number | 446262-90-4 | 863288-34-0 |
| Half-Life | ~6-8 days (albumin-bound, DAC) | ~30 min (pulsatile) |
| Studied For | GH pulsatile release research, GH-axis anti-aging, Growth hormone deficiency, Extended GH secretion | Pulsatile GH simulation, GH secretagogue research, Sleep quality improvement, Stacked with ipamorelin for synergistic GH release |
About CJC-1295 With DAC
A long-acting growth-hormone-releasing peptide; banned in sport.
Read The Full CJC-1295 With DAC MonographAbout CJC-1295 Without DAC
A short-acting growth-hormone-releasing peptide, usually paired with a GHRP; banned in sport.
Read The Full CJC-1295 Without DAC MonographKey Differences
- Reported half-life differs: CJC-1295 With DAC at ~6-8 days (albumin-bound, DAC) versus CJC-1295 Without DAC at ~30 min (pulsatile).
- Primary molecular target differs: CJC-1295 With DAC acts on GHRH receptor (GHRHR) on pituitary somatotrophs; sustained GH and IGF-1 elevation; CJC-1295 Without DAC acts on GHRH receptor (GHRHR) on anterior pituitary somatotrophs; augments natural pulsatile GH release.
Continue Researching
CJC-1295 With DAC · CJC-1295 Without DAC · Compare Tool · Research Library
This Comparison Is Provided For In Vitro Laboratory Research Use Only. Not For Human Consumption, Diagnosis, Or Treatment. See The Full Research Disclaimer.